Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company IRX Therapeutics Inc.
DescriptionCombination of IRX-2 and prostate-specific membrane antigen (PSMA) peptides
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today